Daniela Toneatto

3.3k citations

50 papers · 2.4k · h-index 25

Impact in

Microbiology top 0.05%
- Bacterial Infections and Vaccines
Epidemiology top 1%
- Pneumonia and Respiratory Infections
- Influenza Virus Research Studies
- Virology and Viral Diseases
- Respiratory viral infections research
- Infective Endocarditis Diagnosis and Management

Papers in

Epidemiology 48
- Pneumonia and Respiratory Infections 45
- Influenza Virus Research Studies 18
- Virology and Viral Diseases 10
- Respiratory viral infections research 8
- Infective Endocarditis Diagnosis and Management 3
Microbiology 47
- Bacterial Infections and Vaccines 47

Co-authors: Peter Dull (20 shared papers)Ellen Ypma (8 shared papers)Roman Prymula (10 shared papers)Susanna Esposito (11 shared papers)Matthew D. Snape (11 shared papers)Andrew J. Pollard (11 shared papers)Alan Kimura (5 shared papers)Tessa M. John (6 shared papers)
Journals: Vaccine (13 papers)Human Vaccines & Immunotherapeutics (10 papers)The Pediatric Infectious Disease Journal (5 papers)Canadian Medical Association Journal (3 papers)JAMA (2 papers)
Partner nations: Italy United Kingdom United States

In The Last Decade

Daniela Toneatto

49 papers receiving 2.2k citations

Peers

Countries citing papers authored by Daniela Toneatto

Since Specialization

Citations

This map shows the geographic impact of Daniela Toneatto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Toneatto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Toneatto more than expected).

Fields of papers citing papers by Daniela Toneatto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniela Toneatto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Toneatto. The network helps show where Daniela Toneatto may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniela Toneatto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniela Toneatto Line = papers co-authored together Daniela Toneatto links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Multicenter, Open‐Label, Randomized Phase II Controlled Trial of an Investigational Recombinant Meningococcal Serogroup B Vaccine With and Without Outer Membrane Vesicles, Administered in Infancy Clinical Infectious Diseases ·Jamie Findlow, Ray Borrow, Matthew D. Snape, Tom Dawson, Ann Holland, Tessa M. John, A. E. J. Evans, Karen L. Telford, Ellen Ypma, Daniela Toneatto, Philipp Oster, Elizabeth Miller, Andrew J. Pollard	2010	226
2	Immunogenicity and Tolerability of Recombinant Serogroup B Meningococcal Vaccine Administered With or Without Routine Infant Vaccinations According to Different Immunization Schedules JAMA ·Nicoletta Gossger, Matthew D. Snape, Ly‐Mee Yu, Adam Finn, Gianni Bona, Susanna Esposito, Nicola Principi, Javier Díez‐Domingo, Étienne Sokal, Birgitta Becker, Dorothee Kieninger, Roman Prymula, Peter Dull, Ellen Ypma, Daniela Toneatto, Alan Kimura, Andrew J. Pollard, for the European MenB Vaccine Study Group	2012	217
3	Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials The Lancet ·Timo Vesikari, Susanna Esposito, Roman Prymula, Ellen Ypma, Igor Kohl, Daniela Toneatto, Peter Dull, Alan Kimura	2013	209
4	Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study The Lancet ·Marı́a Elena Santolaya, Miguel L. O’Ryan, María Teresa Valenzuela, Valeria Prado, Rodrigo Vergara, Alma Muñoz, Daniela Toneatto, Gabriela Graña, Huajun Wang, Ralf Clemens, Peter Dull	2012	199
5	Immunogenicity of Two Investigational Serogroup B Meningococcal Vaccines in the First Year of Life The Pediatric Infectious Disease Journal ·Matthew D. Snape, Tom Dawson, Philipp Oster, A. E. J. Evans, Tessa M. John, Brigitte Ohene-Kena, Jamie Findlow, Ly‐Mee Yu, Ray Borrow, Ellen Ypma, Daniela Toneatto, Andrew J. Pollard	2010	159
6	A Multi-Component Meningococcal Serogroup B Vaccine (4CMenB): The Clinical Development Program Drugs ·Miguel O’Ryan, Jeffrey J. Stoddard, Daniela Toneatto, James Wassil, Peter Dull	2013	128
7	An MF59-adjuvanted inactivated influenza vaccine containing A/Panama/1999 (H3N2) induced broader serological protection against heterovariant influenza virus strain A/Fujian/2002 than a subunit and a split influenza vaccine Vaccine ·Giuseppe Lo Giudice, Anke Hilbert, Roberto Bugarini, Ada Minutello, О. Н. Попова, Daniela Toneatto, Ines Schoendorf, Astrid Borkowski, Rino Rappuoli, Audino Podda	2006	97
8	A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine (I) Human Vaccines & Immunotherapeutics ·Roman Prymula, Susanna Esposito, Gianvincenzo Zuccotti, Fang Xie, Daniela Toneatto, Igor Kohl, Peter Dull	2014	81
9	Immunogenicity and Safety of a Multicomponent Meningococcal Serogroup B Vaccine and a Quadrivalent Meningococcal CRM ₁₉₇ Conjugate Vaccine against Serogroups A, C, W-135, and Y in Adults Who Are at Increased Risk for Occupational Exposure to Meningococcal Isolates Clinical and Vaccine Immunology ·Alan Kimura, Daniela Toneatto, A. Kleinschmidt, Wang Hua-jun, Peter Dull	2010	78
10	The first use of an investigational multicomponent meningococcal serogroup B vaccine (4CMenB) in humans Human Vaccines ·Daniela Toneatto, Shevqet Ismaili, Ellen Ypma, Kay Vienken, Philipp Oster, Peter Dull	2011	71
11	Persistence of antibodies in adolescents 18−24 months after immunization with one, two, or three doses of 4CMenB meningococcal serogroup B vaccine Human Vaccines & Immunotherapeutics ·Marı́a Elena Santolaya, Miguel O’Ryan, María Teresa Valenzuela, Valeria Prado, Rodrigo Vergara, Alma Muñoz, Daniela Toneatto, Gabriela Graña, Wang Hua-jun, Peter Dull	2013	66
12	Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose Canadian Medical Association Journal ·Matthew D. Snape, Praveen Saroey, Tessa M. John, Hannah R. Robinson, Sarah Kelly, Nicoletta Gossger, Ly‐Mee Yu, Huajun Wang, Daniela Toneatto, Peter Dull, Andrew J. Pollard	2013	61
13	Neisseria meningitidisfactor H-binding protein fHbp: a key virulence factor and vaccine antigen Expert Review of Vaccines ·Kate L. Seib, Maria Scarselli, Maurizio Comanducci, Daniela Toneatto, Vega Masignani	2015	58
14	Antibody responses and HIV-1 viral load in HIV-1-seropositive subjects immunised with either the MF59-adjuvanted influenza vaccine or a conventional non-adjuvanted subunit vaccine during highly active antiretroviral therapy Vaccine ·Anna Maria Iorio, Daniela Francisci, Barbara Camilloni, Giuliano Stagni, Matteo Martino, Daniela Toneatto, Roberto Bugarini, Mariella Neri, Audino Podda	2003	58
15	Emerging experience with meningococcal serogroup B protein vaccines Expert Review of Vaccines ·Daniela Toneatto, Mariagrazia Pizza, Vega Masignani, Rino Rappuoli	2017	53
16	Reduced schedules of 4CMenB vaccine in infants and catch-up series in children: Immunogenicity and safety results from a randomised open-label phase 3b trial Vaccine ·Federico Martinón‐Torres, Marco Aurélio Palazzi Sáfadi, Alfonso Carmona Martínez, Pilar Infante Marquez, Juan Carlos Tejedor Torres, Lily Yin Weckx, Edson Duarte Moreira, Ilhem Mensi, Marco Calabresi, Daniela Toneatto	2017	39
17	Antibody persistence and booster response in adolescents and young adults 4 and 7.5 years after immunization with 4CMenB vaccine Vaccine ·Terry Nolan, Marı́a Elena Santolaya, Ferdinandus de Looze, Helen Marshall, Peter Richmond, Sam Henein, Paul Rheault, Ken Heaton, Kirsten P. Perrett, Hartley Garfield, Anil Kumar Gupta, Murdo Ferguson, Diego D’Agostino, Daniela Toneatto, Miguel O’Ryan	2019	38
18	A phase II randomized controlled trial of a multicomponent meningococcal serogroup B vaccine, 4CMenB, in infants (II) Human Vaccines & Immunotherapeutics ·Susanna Esposito, Roman Prymula, Gianvincenzo Zuccotti, Fang Xie, Michelangelo Barone, Peter Dull, Daniela Toneatto	2014	37
19	Bactericidal Antibody Persistence 2 Years After Immunization With 2 Investigational Serogroup B Meningococcal Vaccines at 6, 8 and 12 Months and Immunogenicity of Preschool Booster Doses The Pediatric Infectious Disease Journal ·Matthew D. Snape, John Philip, Tessa M. John, Hannah Robinson, Sarah Kelly, Nicoletta Gossger, Ly‐Mee Yu, Claudia Kittel, Daniela Toneatto, Peter Dull, Andrew J. Pollard	2013	36
20	A phase III observer-blind randomized, controlled study to evaluate the immune response and the correlation with nasopharyngeal carriage after immunization of university students with a quadrivalent meningococcal ACWY glycoconjugate or serogroup B meningococcal vaccine Vaccine ·Robert C. Read, Peter Dull, Xilian Bai, Kate Nolan, Jamie Findlow, Rohit Bazaz, A. Kleinschmidt, Maggie McCarthy, Wang Hua-jun, Daniela Toneatto, Ray Borrow	2016	35

About Daniela Toneatto

Daniela Toneatto is a scholar working on Epidemiology, Microbiology, Public Health, Environmental and Occupational Health, Health and Immunology, having authored 50 papers that have together received 2.4k indexed citations. Recurring topics across this work include Bacterial Infections and Vaccines (47 papers), Pneumonia and Respiratory Infections (45 papers), Influenza Virus Research Studies (18 papers), Virology and Viral Diseases (10 papers), Respiratory viral infections research (8 papers), Neonatal and Maternal Infections (6 papers), Infective Endocarditis Diagnosis and Management (3 papers) and Vaccine Coverage and Hesitancy (2 papers). The work is most often cited by research in Microbiology (2.0k citations), Epidemiology (2.0k citations), Health (133 citations), Endocrinology (60 citations) and Immunology (244 citations). Daniela Toneatto has collaborated with scholars based in Italy, United Kingdom and United States. Frequent co-authors include Peter Dull, Ellen Ypma, Roman Prymula, Susanna Esposito, Matthew D. Snape, Andrew J. Pollard, Alan Kimura, Tessa M. John, Philipp Oster and Igor Kohl. Their work appears in journals such as Vaccine, Human Vaccines & Immunotherapeutics, The Pediatric Infectious Disease Journal, Canadian Medical Association Journal and JAMA.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Daniela Toneatto

Impact in

Papers in i

In The Last Decade

Daniela Toneatto

Peers

Countries citing papers authored by Daniela Toneatto

Fields of papers citing papers by Daniela Toneatto

All Works

About Daniela Toneatto

Explore authors with similar magnitude of impact

Papers in